Patent Issued for Dysregulation of trauma regulation pathway treatment and monitoring techniques (USPTO 12150984).

A patent has been issued for techniques related to the dysregulation of the trauma regulation pathway, focusing on addressing physiological conditions associated with this pathway. The patent discusses the activation and modulation of the renin-angiotensin system and local sensory neurons in response to wounds or traumatic injuries. It highlights the importance of maintaining the balance of this pathway to prevent inappropriate activation or lack of downregulation. The patent also includes methods for modulating immune responses in subjects by applying ultrasound energy to internal tissues and measuring changes in circulating biomarkers. [Extracted from the article]